Zion Market Research has published a new report titled “Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global antifungal drug market accounted for around USD 11.30 billion in 2015 and is expected to reach approximately USD 14.10 billion by 2021, growing at a CAGR of around 3.6% between 2015 and 2021.
Fungi are a diverse group of microorganisms that have modified themselves to remain alive in a wide array of environments. These environments may vary from the human body to discrete areas of nature. Fungi can produce diverse human infections ranging from superficial skin infections to internal organ invasion in the body. These viable infections usually happen due to decrease in natural human defenses/immune system or due to heavy exposure to the fungus. Selection of therapies for treating fungal infections based on the type of infection or type of fungus involved in infection. Topical/superficial infections are usually treated with topical agents whereas peripheral infection is treated with systemic therapy.
Request For Free Sample Report: https://goo.gl/YPNHr1
Globally, antifungal drug market has been accelerated due to the continuous rise in the percentage of fungal infections especially the ringworm infection. Furthermore, lack of awareness coupled with self-medication is considered as major key factors which are expected to promotes the growth of antifungal drug market. Moreover many lifestyle-related factors, such as sedentary lifestyle, eating junk food which may lead to weaken the immune system and thus promote the fungal growth. However, high penetration of conventional drugs is the key restraining factor for the growth of anti-fungal drug market. Nonetheless, ongoing research and development in prevention and treatment of fungal infection like to bring growth avenues nearby future.
Based on drug type, the global market of the antifungal drug is bifurcated into five types: echinocandins, azoles, ployenes, allylamines, and others. Azoles are systemically acting antifungal drug which includes fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole. The echinocandins are lipopeptides derived from natural fungal fermentation products. They include anidulafungin, caspofungin, and micafungin. Azole derivative was the leading derivatives in term of generating revenue in 2015 and this growth is expected to continue within the forecast period. The growth is attributed due to effective price and fungicidal properties of azole derivatives like ketokonazole, itaconazole etc.
Inquiry more about this report: https://goo.gl/jqEQeq
Based on therapeutic indication, the global market of the antifungal drug is bifurcated into four types: aspergillosis, dermatophytosis, candidiasis and others. The most commonly encountered fungal infections are those that affect the skin layers. Approximately 1-2% of the world’s population is affected by dermatophytoses (superficial fungal infections of the skin). Seborric dermatisis, ringworm infection, jock itch are the examples of various topical fungal infections.
Based on the dosage form, the global market of the antifungal drug is bifurcated into four types: powders, ointments, drugs, and pastes. Over the counter, antifungal drugs like clo-trimoxazole (sulphamethoxazole + trimethoprim) are available in powder, ointment form and can be easily obtained without doctor/physician prescriptions. Whereas, the majority of the oral antifungal drugs are prescription based medicines and are available in various dosage forms such as tablets, capsules, and suspensions. Powder, the ointment is covering approximately more than 55% of the antifungal drug market.
Based on geographies, the global market for the antifungal drug is bifurcated into five types: North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global antifungal market, followed by Europe. This growth is attributed due to raising awareness related to health care in this region. Moreover, antifungal drug market has a huge opportunity in the emerging markets of Asia Pacific region due to an increased standard of living, a large pool of patient in this region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of fungal infection, increasing government support and growing upper-middle-class population and rise in disposable income level in this region. Understanding the rising episodes of fungal infections in the country, the government employed various measures on its own including a public-private partnership (PPP). This development is largely responsible for propelling the Indian market for the antifungal drug.
Browse the full report at: https://goo.gl/gZeecq
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global antifungal drug market include Asperqillus, Alternaria, Abbott Laboratories, Pfizer, Glaxosmithkline, Bayer Healthcare, Novartis, Sanofi-Aventis, Merck & Co., Kramer Laboratories, Enzon Pharmaceuticals, and Gilead.
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.